Kezar Life Ownership
| KZR Stock | USD 5.89 0.31 5.56% |
Shares in Circulation | First Issued 2017-03-31 | Previous Quarter 7.3 M | Current Value 73 M | Avarage Shares Outstanding 42.1 M | Quarterly Volatility 25.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Kezar |
Kezar Stock Ownership Analysis
About 62.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.32. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kezar Life Sciences recorded a loss per share of 13.12. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 30th of October 2024. Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company was incorporated in 2015 and is based in South San Francisco, California. Kezar Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. To find out more about Kezar Life Sciences contact the company at 650 822 5600 or learn more at https://www.kezarlifesciences.com.Besides selling stocks to institutional investors, Kezar Life also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Kezar Life's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Kezar Life's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Kezar Life Quarterly Liabilities And Stockholders Equity |
|
Kezar Life Insider Trades History
About 12.0% of Kezar Life Sciences are currently held by insiders. Unlike Kezar Life's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Kezar Life's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Kezar Life's insider trades
Kezar Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Kezar Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kezar Life Sciences backward and forwards among themselves. Kezar Life's institutional investor refers to the entity that pools money to purchase Kezar Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Advisers, Llc | 2024-12-31 | 100.1 K | Renaissance Technologies Corp | 2024-12-31 | 87.7 K | Qiming U.s. Ventures Management, Llc | 2024-12-31 | 82.9 K | Blackrock Inc | 2024-12-31 | 82.9 K | Geode Capital Management, Llc | 2024-12-31 | 66.6 K | Two Sigma Investments Llc | 2024-12-31 | 62 K | Shay Capital Llc | 2024-12-31 | 59.2 K | Goldman Sachs Group Inc | 2024-12-31 | 52.3 K | Bml Capital Management Llc | 2024-12-31 | 48.7 K | Tang Capital Management Llc | 2024-12-31 | 720 K | Suvretta Capital Management, Llc | 2024-12-31 | 716.8 K |
Kezar Life Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kezar Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kezar Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Kezar Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kezar Life Outstanding Bonds
Kezar Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kezar Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kezar bonds can be classified according to their maturity, which is the date when Kezar Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Kezar Life Corporate Filings
| 6th of March 2025 Other Reports | ViewVerify | |
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 3rd of March 2025 Other Reports | ViewVerify | |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Pair Trading with Kezar Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kezar Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will appreciate offsetting losses from the drop in the long position's value.Moving together with Kezar Stock
Moving against Kezar Stock
| 0.76 | CPIX | Cumberland Pharmaceuticals Downward Rally | PairCorr |
| 0.73 | FNA | Paragon 28 | PairCorr |
| 0.72 | CMRX | Chimerix | PairCorr |
The ability to find closely correlated positions to Kezar Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kezar Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kezar Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kezar Life Sciences to buy it.
The correlation of Kezar Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kezar Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kezar Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kezar Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.